Before purchasing GHK-Cu, consult a healthcare provider to discuss your skin health goals, baseline tissue integrity, and any conditions affecting wound healing or immune function
The CV safety of a lower dose of liraglutide (1.8 mg, Victoza, Novo Nordisk) in people with T2D was established in the Liraglutide Effect and Action in Diabetes: Evaluation of CV Outcome Results (LEADER) study, showing a 13% reduction in major CV events over an average of 3.8 years [44]
Pfizer's own clinical trials diversity page acknowledges the underlying problem the initiative was built to address: Black Americans make up roughly 13% of the US population but only 5% of clinical trial participants ( [106] ), a gap consistent with the SCRS oncology-specific survey figure cited earlier and with the Health Affairs finding of one-third proportional enrollment
Honest Peptide is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B